Antitumor effect of insulin-like growth factor-1 receptor inhibition in head and neck squamous cell carcinoma

Christine E Lehman1, Ashraf A Khalil1,2, Mark J Axelrod1,3

  • 1Department of Otolaryngology-Head and Neck Surgery, University of Virginia Health System, Charlottesville, Virginia, U.S.A.

The Laryngoscope
|August 22, 2019
PubMed
Abstract

Insights

Higher insulin-like growth factor-1 receptor (IGF1R) expression correlates with poorer survival in oral cavity squamous cell carcinoma. Two IGF1R tyrosine kinase inhibitors (TKIs) showed anticancer effects in head and neck squamous cell carcinoma cell lines.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Insulin-like growth factor-1 receptor (IGF1R) signaling is implicated in therapeutic resistance in head and neck squamous cell carcinoma (HNSCC).
  • Small molecule tyrosine kinase inhibitors (TKIs) targeting IGF1R activity present a potential therapeutic strategy for HNSCC.

Purpose of the Study:

  • To investigate the association between IGF1R expression and survival in oral cavity (OC) cancer.
  • To evaluate the in vitro antitumor effects of two IGF1R-TKIs, OSI-906 and BMS-754807, on HNSCC cell lines.

Main Methods:

  • Survival analysis using clinical data and tissue microarrays for IGF1R expression.
  • In vitro assays including immunoblotting, proliferation, viability, clonogenic survival, flow cytometry, and reverse phase protein array (RPPA) to assess drug responses.

Main Results:

  • Increased IGF1R expression was linked to reduced 5-year survival in stage III/IV oral cavity squamous cell carcinoma (OCSCC) patients (P=0.029).
  • Both OSI-906 and BMS-754807 inhibited IGF1R and Akt phosphorylation and proliferation in HNSCC cells; BMS-754807 demonstrated greater potency.
  • Both TKIs reduced HNSCC cell viability, with OSI-906 achieving complete cell elimination at 10 μM. RPPA revealed broad pathway inhibition, including HER3, Src, paxillin, and ezrin phosphorylation.

Conclusions:

  • OSI-906 and BMS-754807 effectively inhibit IGF1R activity in HNSCC cell lines, reducing pro-survival signaling.
  • These IGF1R antagonists exhibit antiproliferative and proapoptotic effects, suggesting potential as adjuvant therapies for HNSCC.

Related Concept Videos

Arteries of the Head and Neck01:26

Arteries of the Head and Neck

The human body's intricate network of arteries ensures that every organ system receives the necessary oxygen and nutrients for optimal function. The arterial network in the head and neck region is particularly complex, providing vital blood flow to the brain, eyes, and other critical structures. Prominent arteries in this region include the internal carotid arteries and the vertebral arteries.
The internal carotid arteries supply blood to the anterior portion of the cerebrum. They enter the...
3.0K
Veins of Head and Neck01:19

Veins of Head and Neck

The blood drainage from the head and neck is primarily managed by three pairs of veins: the external jugular, internal jugular, and vertebral veins. The external jugular veins drain superficial scalp and face structures, passing over the sternocleidomastoid muscles to empty into the subclavian veins.
On the other hand, the vertebral veins, unlike their arterial counterparts, are not primarily responsible for brain drainage. Instead, they drain the cervical vertebrae, spinal cord, and some small...
5.3K
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
2.8K
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
3.2K
Factors Influencing Microbial Growth: pH01:29

Factors Influencing Microbial Growth: pH

Microorganisms are classified as acidophiles, neutrophiles, or alkaliphiles based on their pH growth preferences, reflecting their adaptations to specific environments. Maintaining a stable intracellular pH is critical for macromolecular stability and enzymatic activity, which can be challenged by external pH variations.Neutrophiles, such as Escherichia coli, grow optimally between pH 5.5 and 8.0. These microorganisms inhabit neutral or slightly acidic environments and employ mechanisms like...
1.1K
Factors Influencing Microbial Growth: Temperature01:27

Factors Influencing Microbial Growth: Temperature

Microorganisms display remarkable adaptations, enabling them to thrive in diverse ecological niches across a wide range of temperatures. Temperature profoundly influences microbial growth by affecting enzymatic activity, membrane fluidity, and other cellular processes.Each microorganism operates within a specific temperature range defined by three cardinal points: minimum, optimum, and maximum. Below the minimum temperature, membranes lose fluidity, halting transport processes. Above the...
1.1K